How Remote Patient Monitoring Technology Is Transforming Clinical Research
The growing complexity of clinical trials and the difficulty of keeping patients enrolled are two of the leading challenges facing sites today. Protocols are becoming…
Clinical Trials
Balancing Innovation and Clinical Trial Efficiency – Is there a Middle Ground?
To advance science without compromising trial efficiency, we must prioritise simpler user journeys and connected data. Clinical trials are constantly pushing the boundaries of innovation….
Transforming Clinical Trials with Digital Platforms for Patient Recruitment
Patient recruitment is a crucial element in clinical trials, often determining their success. Traditional recruitment methods face significant challenges, leading to delays and incomplete studies….
Democratising Access to Clinical Trials Across the EU
Winston Churchill once famously said; “Healthy citizens are the greatest asset any country can have.” The importance of a healthy population is why we see…
Patients Are Waiting: Speeding Time to Treatment in Rare Disease
Companies are overcoming challenges to develop, launch, and educate on new rare disease medicines and treatment faster. Rare diseases are no longer rare. Every year,…
Current State of Drug Development, Clinical Trials, and Precision Measures
Drug research and development can cost up to $6bn per asset and take an average of 13 years from discovery to approval1. In this expensive…
Novel Drugs: The Case for Applied Behavioural Science in Driving Take up
Behavioural science’s time has come in the pharma industry, as medical communications adapt to a more ambitious and diverse treatment landscape. Here, Alpharmaxim’s William Hind…
Modern by (Trial) Design: Shedding Legacy EDC Systems to Gain Clinical Capacity
As trials become increasingly complex, companies share how leaving behind legacy EDC systems can save thousands of hours during study build and testing. In today’s…
Digital Tools can Help Patients and Healthcare Providers Navigate the Rapidly Changing Oncology Treatment Landscape
The field of oncology is rapidly growing and evolving. In 2022, global spending on cancer medicines was approximately 196 billion USD and this number is…
Revolutionising Drug Development: Key Takeaways from the ICON Biotech Survey
In the dynamic landscape of biotechnology, ICON’s recent survey of over 100 leaders from the biotech industry dissects the challenges and opportunities faced by biotech…